Loading...

Anew Medical, Inc.

WENAWNASDAQ
Healthcare
Biotechnology
$0.04
$-0.00(-0.25%)

Anew Medical, Inc. (WENAW) Company Profile & Overview

Explore Anew Medical, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Anew Medical, Inc. (WENAW) Company Profile & Overview

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

SectorHealthcare
IndustryBiotechnology
CEOJoseph Sinkule

Contact Information

833 931 6330
13576 Walnut Street, Omaha, NE, 68144

Company Facts

1 Employees
CountryUS

Frequently Asked Questions

;